Amyotrophic lateral sclerosis (ALS)-causing mutations clearly implicate ubiquitously expressed and predominantly nuclear RNA binding proteins (RBPs), which form pathological cytoplasmic inclusions in this context. However, the possibility that wild-type RBPs mislocalize without necessarily becoming constituents of ALS cytoplasmic inclusions themselves remains unexplored. We hypothesized that nuclear-to-cytoplasmic mislocalization of the RBP Fused in Sarcoma (FUS), in an unaggregated state, may occur more widely in ALS that previously recognized. To address this hypothesis, we analysed motor neurons (MNs) from an human ALS induced-pluripotent stem cells (iPSC) model caused by the VCP mutation.
Introduction
Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive neurodegenerative condition, which remains incurable due to our incomplete understanding of the molecular pathogenesis. Genetic discoveries in ALS strongly implicate ubiquitously expressed regulators of RNA-processing (Taylor et al. , 2016) . Pathologically, in 97% of cases TDP-43 protein is mislocalized from the nucleus to the cytoplasm, where it aggregates (Neumann et al. , 2006) . However, ALS-causing mutations in Fused in Sarcoma (FUS) and superoxide dismutase (SOD1) conspicuously lack TDP-43 proteinopathy in the majority of cases (Mackenzie et al. , 2007) . FUS aggregation is a recognized feature of FUS mutation-related ALS (Vance et al. , 2009 ) . However, the concept that wild-type FUS nuclear-to-cytoplasmic mislocalisation -rather than aggregation -might be a more widespread feature of other forms of ALS has not been systematically assessed to our knowledge. Indeed such mislocalisation may have evaded detection thus far due to bias towards studying aggregates/inclusions rather than perturbed subcellular localisation of unaggregated proteins alone. This possibility is strengthened by the facts that i) impaired nuclear-cytoplasmic compartmentalization is increasingly recognized as a key feature of ALS (Boeynaems et al. , 2016) and ii) FUS is known to shuttle between the nucleus and cytoplasm.
Here we systematically investigated FUS protein localisation across a human iPSC model, mouse transgenic models and human post-mortem tissue from multiple cases of sporadic ALS. We find that the nuclear-to-cytoplasmic mislocalisation of FUS is a more widespread feature of ALS than previously recognized. Furthermore, we present evidence that supports a putative molecular mechanism for this mislocalisation through interaction between FUS and the aberrant intron retaining SFPQ transcript.
Results

Nuclear-to-cytoplasmic mislocalisation of FUS in human and mouse
VCP-mutant ALS models
We have previously reported robust differentiation of human induced-pluripotent stem cells (hiPSC) into highly enriched (>85%) cultures of comprehensively validated and functionally characterized spinal cord motor neurons (Hall et al. , 2017; Maffioletti et al. , 2018) . Using this approach, we have found clear molecular pathogenic phenotypes in a human iPSC model of VCP-related ALS (4 clones from 2 patients with the following mutations: VCP 155C and VCP R191Q ) (Hall et al. , 2017; Luisier et al. , 2018) . We harnessed this well characterized ALS model to investigate the subcellular localisation of FUS protein, which revealed a modest but statistically significant (P < 0.001) decrease in nuclear-to-cytoplasmic localisation during motor neuron differentiation ( Figure 1A ). We next sought to validate this finding in vivo by examining tissue sections from a mouse VCP transgenic model (VCP A232E ).
Additionally, we examined tissue from the SOD1 G93A mouse model as a comparator.
Using linear mixed model analysis that accounts for inter-animal variation we showed that although FUS remained within the nucleus in the SOD1 mouse model ( (1)=0.031, p=0.955), nuclear-to-cytoplasmic mislocalisation abounded in the VCP χ 2 mouse model, with a reduction in FUS nuclear to cytoplasmic ratio of -4.0176 ± 1.1775 ( (1)=8.164, p=0.0042) ( Figure 1B) . χ 2
Nuclear-to-cytoplasmic mislocalisation of FUS in human sporadic ALS
Having established that FUS was mislocalized in VCP-related ALS models, but not in SOD1, we next sought to address the generalizability of this finding across sporadic forms of ALS (which represent 90% of all cases). To this end, we examined post-mortem spinal cord tissue from 12 sporadic ALS cases and 8 healthy controls ( Figure 2A ). We found clear evidence of nuclear-to-cytoplasmic FUS mislocalisation in these sporadic ALS cases, but in the absence of cytoplasmic FUS inclusions .
vitro model of ALS which associates with increase apoptosis (Kiskinis et al. , 2014) .
We thus investigated whether changes in FUS subcellular localisation in sALS samples accompany alterations in cell morphology. Using single-cell analysis of nuclear and cell size, we demonstrated significant reductions in both nuclear and cytoplasmic areas in sALS vs control MNs ( Figure 2B ) which did not correlate with reduction in FUS nuclear-to-cytoplasmic localisation in sALS cases ( Figure 2C ).
FUS binds to an aberrantly retained intron within the SFPQ transcript, which is exported from the nucleus
Having found clear evidence that FUS nuclear-to-cytoplasmic mislocalisation is more widespread in ALS than previously recognized, we sought to understand it's molecular interplay with 167 aberrant intron retaining transcripts that we recently described in ALS (Luisier et al. , 2018) . To this end we analysed data from a method called individual-nucleotide resolution cross-linking and immunoprecipitation (iCLIP), which allows identification of the RNA binding targets of the FUS protein. Using this approach, we found that the FUS protein binds extensively to the aberrantly retained intron 9 within the SFPQ transcript ( Figure 3A&B ), which we identified as the most significantly retained intron across diverse ALS mutations (Luisier et al. , 2018) . We next confirmed that the SFPQ intron-retaining transcript is exported to the cytoplasm using nuclear-cytoplasmic cellular fractionation and qPCR ( Figure 3C) , showing an increased proportion of SFPQ intron retaining transcript in the cytosol of VCP mutant cultures. We employed single molecule RNA fluorescence in situ hybridization (smFISH) as orthogonal validation that this transcript is exported from the nucleus ( Figure 3D ).
Discussion
The core finding of our study is that the FUS protein is mislocalised from the nucleus to the cytoplasm in cases beyond FUS mutation-related ALS. Specifically, we find FUS mislocalisation in VCP mutation-related ALS and, crucially, in sporadic ALS.
Our findings have been carefully cross-validated in iPSC lines (4 VCP mutant and 4 control iPSC lines), a mouse transgenic model (3 VCP mutant and 3 control mice), and post-mortem tissue (12 sporadic ALS cases and 8 control cases). The pervasive mislocalisation of FUS has likely evaded detection thus far as FUS largely remains unaggregated in the cytoplasm, rather than forming part of the TDP-43 aggregates in sporadic ALS cases.
Our findings support a model whereby FUS mislocalisation from the nucleus to the cytoplasm occurs in the majority of ALS cases, but it generally does not appear to aggregate in the cytoplasm. Nuclear loss of FUS protein may impair pre-mRNA splicing whilst the possibility of a cytosolic toxic gain of function is also noteworthy in light of recent studies (López-Erauskin et al. , 2018) . Interestingly, TDP-43 aggregation is also observed in most familial and sporadic ALS cases, except from those caused by SOD1 mutations. Thus, FUS mislocalisation appears to occur in a similar majority of cases to TDP-43 aggregation. Importantly, the mislocalised FUS is observed in mouse and iPSC models at early stages, before the onset of TDP-43 aggregates, indicating that the mislocalised unaggregated FUS might play a causative role early in the ALS disease process, perhaps by creating a more aggregation-prone cytoplasmic environment.
Our analysis of iCLIP data suggest that FUS binds avidly to the aberrantly retained intron of the SFPQ transcript in ALS. Cumulatively, our data are consistent with a working hypothesis that wild-type FUS might travel out of the nucleus when bound to the aberrantly retained intron 9 of the SFPQ transcript in ALS ( Figure 3E ), though confirmation of such a mechanism will require detailed molecular follow-up work. The lack of evidence for FUS mislocalisation in SOD1 mutant MNs despite the presence of SFPQ intron retention (Luisier et al. , 2018) suggests a mutation-dependent variation in the repertoire of RBPs that engage intron-retaining transcripts. SFPQ protein can be sequestered by the SFPQ intron-retaining transcript across the different mutations, whereas in the context of SOD1 mutations, FUS might not be significantly sequestered and/or exported in this manner.
In summary we report a previously unrecognized widespread mislocalisation (but not aggregation) of FUS in ALS, and propose a putative context-specific mechanism for this through its interaction with the ALS-related aberrantly retained intron 9 in SFPQ. These findings raise the prospect of targeting the nuclear mislocalistion of unaggregated FUS as a putative therapeutic strategy in ALS.
Methods
iPSC culture and motor neuron differentiation
iPSC were maintained using standard protocols. Motor neuron differentiation was carried out as previously described (Hall et al. , 2017; Luisier et al. , 2018) . See
Supplementary Methods for more detailed information. Details of iPSC lines are provided in Table S1 .
Animals, transgenic models and tissue processing Research Hospital, Memphis, TN, USA and are described in (Custer et al. , 2010) and bred to wild-type C57 Black 6 ( C57/B6 ) background. Wild type C56BL/6-SJL mixed background (Jackson Laboratories) were used as control. For tissue collection, animals were injected with terminal anaesthesia (pentobarbital sodium, Euthatal) and were transcardially perfused with 4% paraformaldehyde. The lumbar region of the spinal cord was removed and post-fixed with 4% paraformaldehyde and cryoprotected overnight with 30% sucrose; 10 or 20μm serial transverse cryosections were cut for immunofluorescence staining .
Human post mortem tissue
Snap frozen tissue sections derived from lumbar spinal cords of three age and sex matched sporadic ALS patients (see Table S2 ). 
Data analysis of FUS protein sub-cellular localization
We used R (R Core Team, 2012) and lme4 (Bates, Maechler & Bolker, 2012) to perform linear mixed effects analysis of the relationship between FUS localisation and VCP or SOD1 mutation, as well as with sporadic ALS, that accounts for idiosyncratic variation due to either animal or individual differences. As fixed effects, we either entered the mutation or the ALS disease variable into the model. As random effects, we had intercepts for either animals (SOD1, VCP) or patients and batches. Visual inspection of residual plots did not reveal any obvious deviations from homoscedasticity or normality. P-values were obtained by likelihood ratio tests of the full model with the effect in question against the model without the effect in question.
Mapping of iCLIP data
Raw FUS iCLIP data can be accessed via https://imaps.genialis.com/ (Attig et al. , 2018) . Before alignment, two-stage adapter removal was performed using Cutadapt according to the ENCODE iCLIP standard operating procedure. A two-stage approach was also used for alignment. First, Bowtie2 was used to remove reads aligning to rRNA or tRNA. Then, STAR was used to align the remaining reads to GRCh38, with only uniquely mapping reads retained. PCR duplicates were collapsed based on the unique molecular identifiers and mapping locations. The nucleotide-resolution crosslink position was calculated as the coordinate immediately preceding the reverse transcription truncation event.
Compliance with ethical standards
For human iPSC work: Informed consent was obtained from all patients and healthy controls in this study. Experimental protocols were all carried out according to healthy controls (n=8) and patients with sporadic ALS (sALS) (n=12). MN cytoplasm was identified by ChAT staining, nuclei were counterstained with DAPI. N/C ratio of FUS immunoreactivity was measured as described in Figure 1B . Only MNs with a visible nucleus were considered for the analysis. We used R (R Core Team, 2012) and lme4 (Bates et al. , 2015) to 
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Derivation of Human Fibroblasts and iPSC
Dermal fibroblasts were cultured in OptiMEM +10% FCS medium. The following episomal plasmids were transfected for iPSC generation: pCXLE hOct4 shp53, pCXLE hSK, and pCXLE hUL (Addgene), as previously reported (Okita et al. , 2011) .
Details of the lines used in this study are provided in 
